[HTML][HTML] Old and new oral anticoagulants: food, herbal medicines and drug interactions
…, A Ravani, D Sansaro, M Amato, JP Kitzmiller… - Blood reviews, 2017 - Elsevier
The most commonly prescribed oral anticoagulants worldwide are the vitamin K antagonists
(VKAs) such as warfarin. Factors affecting the pharmacokinetics of VKAs are important …
(VKAs) such as warfarin. Factors affecting the pharmacokinetics of VKAs are important …
[HTML][HTML] Pharmacogenomic testing: relevance in medical practice: why drugs work in some patients but not in others
JP Kitzmiller, DK Groen, MA Phelps… - Cleveland Clinic journal …, 2011 - ncbi.nlm.nih.gov
Genetics may account for much of the variability in our patients’ responses to drug therapies.
This article offers the clinician an up-to-date overview of pharmacogenomic testing, …
This article offers the clinician an up-to-date overview of pharmacogenomic testing, …
Pharmacogenomics of statins: understanding susceptibility to adverse effects
JP Kitzmiller, EB Mikulik, AM Dauki… - Pharmacogenomics …, 2016 - Taylor & Francis
Statins are a cornerstone of the pharmacologic treatment and prevention of atherosclerotic
cardiovascular disease. Atherosclerotic disease is a predominant cause of mortality and …
cardiovascular disease. Atherosclerotic disease is a predominant cause of mortality and …
Physician perspectives on education, training, and implementation of complementary and alternative medicine
SJ Patel, KJ Kemper, JP Kitzmiller - Advances in medical education …, 2017 - Taylor & Francis
Over recent decades, the demand for complementary and alternative medicine (CAM) has
continued to rise in the US. Like the practice of traditional Western medicine, CAM is …
continued to rise in the US. Like the practice of traditional Western medicine, CAM is …
[HTML][HTML] CYP3A4* 22 and CYP3A5* 3 are associated with increased levels of plasma simvastatin concentrations in the cholesterol and pharmacogenetics study cohort
JP Kitzmiller, JA Luzum, D Baldassarre… - Pharmacogenetics …, 2014 - journals.lww.com
Objective Simvastatin is primarily metabolized by CYP3A4. A combined CYP3A4/5
genotype classification, combining the decrease-of-function CYP3A4* 22 and the loss-of-function …
genotype classification, combining the decrease-of-function CYP3A4* 22 and the loss-of-function …
CYP2D6 Genetic Variation and Beta-Blocker Maintenance Dose in Patients with Heart Failure
…, JP Jarvis, MF Christman, W Sadee, JP Kitzmiller - Pharmaceutical …, 2017 - Springer
Purpose This study examined whether a CYP2D6 polymorphism (CYP2D6*4) was related
to beta-blocker maintenance dose in patients with heart failure. Methods Logistic regression …
to beta-blocker maintenance dose in patients with heart failure. Methods Logistic regression …
[PDF][PDF] GATM polymorphism associated with the risk for statin-induced myopathy does not replicate in case-control analysis of 715 dyslipidemic individuals
Statin-induced myopathy (SIM) is the most common reason for discontinuation of statin
therapy. A polymorphism affecting the gene encoding glycine amidinotransferase (GATM …
therapy. A polymorphism affecting the gene encoding glycine amidinotransferase (GATM …
[HTML][HTML] Pharmacogenetics of statin-induced myopathy: a focused review of the clinical translation of pharmacokinetic genetic variants
JA Talameh, JP Kitzmiller - Journal of pharmacogenomics & …, 2014 - ncbi.nlm.nih.gov
Statins are the most commonly prescribed drugs in the United States and are extremely effective
in reducing major cardiovascular events in the millions of Americans with hyperlipidemia…
in reducing major cardiovascular events in the millions of Americans with hyperlipidemia…
[HTML][HTML] Statin pharmacogenomics: pursuing biomarkers for predicting clinical outcomes
JP Kitzmiller, PF Binkley, SR Pandey, AM Suhy… - Discovery …, 2013 - ncbi.nlm.nih.gov
Indicated for treating hyperlipidemias and for the prevention of cardiovascular disease (CVD),
statins rank among the most commonly prescribed drug classes. While statins are …
statins rank among the most commonly prescribed drug classes. While statins are …
Individual and combined associations of genetic variants in CYP3A4, CYP3A5, and SLCO1B1 with simvastatin and simvastatin acid plasma concentrations
Our objective was to evaluate the associations of genetic variants affecting simvastatin (SV)
and simvastatin acid (SVA) metabolism [the gene encoding cytochrome P450, family 3, …
and simvastatin acid (SVA) metabolism [the gene encoding cytochrome P450, family 3, …